Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from EUDA Health Holdings ( (EUDA) ).
On January 7, 2026, EUDA Health Holdings Limited announced that it had amended its previously disclosed warrant agreement with Streeterville Capital, LLC, originally tied to a November 26, 2025 securities purchase agreement and a warrant issued on December 4, 2025 for up to 2,000,000 ordinary shares. The December 16, 2025 amendment lowers the warrant exercise price from US$6.00 to US$4.00 per share and reduces the minimum closing price needed to trigger a forced exercise from US$7.50 to US$6.00, while leaving other terms unchanged, a move that makes the warrants more attractive and could accelerate potential equity issuance and capital inflows, with implications for EUDA’s capital structure and existing shareholders.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based provider of non-invasive and preventive healthcare services across Asia, with a primary focus on Singapore, Malaysia and China. Targeting the fast-growing longevity sector, the company aims to shift regional healthcare from reactive treatment to proactive, longevity-focused care for a rapidly aging population of more than 1.8 billion people, and it also operates a Singapore-based property management business.
Average Trading Volume: 259,900
Technical Sentiment Signal: Sell
Current Market Cap: $86.58M
Find detailed analytics on EUDA stock on TipRanks’ Stock Analysis page.